Neurodegenerative disease management

Top Research Topics at Neurodegenerative disease management?

The discussions in the journal mainly cover the fields of Disease, Dementia, Multiple sclerosis, Psychiatry and Parkinson's disease. The journal focuses on Disease but the discussions also offer insight into other areas such as Physical medicine and rehabilitation, Cognition, Neuroscience, Intensive care medicine and Physical therapy. Research on Cognition addressed in the journal frequently intersections with the field of Clinical psychology.

Many of the studies tackled connect Physical therapy with a similar field of study like Psychological intervention. The concepts on Dementia presented in the journal can also apply to other research fields, including Nursing, Gerontology and Cognitive impairment. While Multiple sclerosis is the focus of Neurodegenerative disease management, it also provided insights into the studies of Observational study, Clinical trial, Internal medicine and Spasticity.

Interdisciplinary research on topics like Internal medicine and In patient are the foci of Neurodegenerative disease management. Depression (differential diagnoses) and Neurology studies are all carried out as a component of the study in Psychiatry presented. The studies tackled, which mainly focus on Parkinson's disease, apply to Dopaminergic as well.

• Disease (42.01%)
• Dementia (21.53%)
• Multiple sclerosis (18.92%)

What are the most cited papers published in the journal?

• Prevention of falls in Parkinson's disease: a review of fall risk factors and the role of physical interventions. (101 citations)
• The sleep-wake cycle and Alzheimer's disease: what do we know? (78 citations)
• Activities of daily living: where do they fit in the diagnosis of Alzheimer’s disease? (74 citations)

Research areas of the most cited articles at Neurodegenerative disease management:

The main points discussed in the published articles deal with Disease, Dementia, Psychiatry, Cognition and Neuroscience. The journal papers feature research on Disease in an attempt to reinforce studies in the field of Pathology. The published articles explore issues in Psychiatry which can be linked to other research areas like MEDLINE, Parkinson's disease, Family caregivers, Personhood and Pediatrics.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Cancer

The previous edition focused in particular on these issues:

Neurodegenerative disease management mainly tackles studies in Disease, Internal medicine, Parkinson's disease, Dementia and Multiple sclerosis. Disease management (health) is the primary subject of Disease works presented in it. The journal tackles studies in Oncology and the interrelated subject of Clinical trial, Neurofilament light, COMT inhibitor and Temporal information to gain insights into Internal medicine.

The research on Parkinson's disease tackled can also make contributions to studies in the areas of Psychological intervention, Physical therapy, Depression (differential diagnoses) and Medical record. Dementia research featured in it incorporates concerns from various other topics such as Randomized controlled trial and Cognition. The study of Multiple sclerosis encompasses disciplines such as Intensive care medicine, as well as fields such as MEDLINE, Obesity, Weight loss and Nutrition Interventions, all of which overlap with one another.

The most cited articles from the last journal are:

• Telehealth for the cognitively impaired older adult and their caregivers: lessons from a coordinated approach. (9 citations)
• Evaluation of rivastigmine in Alzheimer's disease. (6 citations)
• Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use? (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Neurodegenerative disease management (based on the number of publications) are:

• Andrew J Larner (10 papers) published 2 papers at the last edition the same number as at the previous edition,
• Roland Dominic G. Jamora (8 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• Joe Verghese (8 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Daniela Rae (6 papers) absent at the last edition,
• Robert W. Motl (6 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Neurodegenerative disease management (based on the number of publications) are:

• Walton Centre (11 papers) published 2 papers at the last edition the same number as at the previous edition,
• Newcastle University (11 papers) absent at the last edition,
• University of the Philippines Manila (10 papers) published 3 papers at the last edition, 1 less than at the previous edition,
• Harvard University (9 papers) published 1 paper at the last edition,
• University College London (8 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 26.32% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.16% of all publications and 50.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Nursing and Neurodegenerative Diseases

A significant missing section in the article is the discussion of the important role that nursing plays in managing neurodegenerative diseases. The nursing profession has a crucial involvement in the healthcare industry, particularly in specialties like gerontology, cognitive impairment, and psychiatry which are highly relevant to the management of neurodegeneration. Nurse practitioners are fundamental to the multidisciplinary teams that provide care for patients with neurodegenerative conditions like Alzheimer's, Parkinson's, and Multiple Sclerosis. They administer and manage the patients' medications, monitor their symptoms and advise on lifestyle modifications to improve their quality of life. Moreover, nurse practitioners who specialize in neurology have advanced training to assess, diagnose, and manage neurologic disorders. This can also include the ordering and interpretation of diagnostic tests such as imaging and lab work. For further clarity, one could refer to our detailed guide on how to be a nurse practitioner in Maine. The guide elaborates on the training, skills, and expertise required to excel in this challenging yet rewarding field of nursing practice. By understanding the pivotal role of nurses in neurodegenerative disease management, we can further drive interdisciplinary collaboration and research in this continually evolving field.